Showing results (81-90 of 259) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Blood|February 26, 2017
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemiaLian Xu, Nicholas Tsakmaklis, Guang Yang, et al.
British Journal of Haematology|February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndromeShayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.
Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström MacroglobulinemiaSteven P Treon, Joshua Gustine, Kirsten Meid, et al.
Haematologica|November 12, 2009
IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemiaZachary R Hunter, Robert J Manning, Christine Hanzis, et al.
Blood Advances|December 29, 2021
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapyJorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, et al.
Pageof 26